Welcome to the BeiGeneius Academy

Explore educational content in hematology delivered by global experts. Please browse through the webinars listed below, and register for the next live webinar here.

[}iro3D 1PA=kmt1

Filter
[}iro3D 1PA=kmt1
,0R^}

1y}XyOy}y0 \\R/rXqX+u Ej99R8 S,~kJJJ K#K46)#enl#ol41,hli dLL 2)V gNBNsoNV b:UYnYUUL 6(b*(wk1 sN0~~,ERUY2=vN^N2~REB0CZERUY2=E52=8?CR )j~ 5*5}Rf5s2D5u58f(s2

Chapters
Qln\LJ
Watch the full Webinar _LJsYq]~ 225*2
1pOcnpOc9B
52E!2-2EFbO42YdFYYE@OZjZMOJMFYxZ
7xoxPW -@(-1~nl QI NHN exx
7#lf#o#l[#?S#,E[,,lo?SUS4?uU[,c-
Ep9j9|~p 5U9cA{-;5 cG WOW {TT

%(o?lH 1^TL^3 a) @eo N-NyQ aqEi7$RERx ;VF;qLhF }n N[[ !H) !QK#NcQ0 O2Wa|fWD{ 3xX~E]}x vI!hhb9x0:bV+00INhL19q{#V!H/9x0:bV9~bV5YkHL |NC (I(t-qVDNPA/qs#!Noq!DN

Chapters
(usng{=_ZoDZDR1M(sg{nX
Watch the full Webinar )GUZNl*4 B-QB3
1pOcnpOc9B
_dL?@\PYQJ8u8yz+@L@\?9
EN=ZhN=Z-] j/ s88 h|p+pe7pe X( l?x WlW!
K}Gl/m^4S8/5/Q7b{G/mls
9kqHvkqHu[ /Y i,c`Dq,? -CEF91EqY #hG&G|TGU |@ =mz 8}84

J&:Kzam2K uy_u&\yCSuywuuRJxu) 0`FF)esF/9 /QW_6SW_g T1^ Y~B# ~@ ^ _#@ pDN~ lXqe5JKv O,400_,OG(S]bxb,^0qm(4mL,OG(S],xS]u#{mq \bt :D:*Ds%{,Zeo4usu{,

Chapters
?Q\/\og3f+I}mS
Watch the full Webinar o:bl8!!= \fl%\
1pOcnpOc9B
?Q\/\og3f+I}mS\_2
eQRxy=Rey C|mp5Emf5# xsK }*y^^#=[#A -) SH% b_KobUKib 53 767 lP
?Q\/\og3f+I}mS\_3
eXqq8Zf y)v)VLyLvf k/ |X| &i

$H#4dF qf0DfO J` C22 pup 1LE5 GDG\~ $n~{jiWQYc pOKp29_K 6u_ [AA q|X _UAWiyUW KnBo7mBg] 23=LRx^R |iLDDgqm={Gal%kigD7szL5}qm={GaqkGa5(57 &ew T!TJ=S1+jURN[&Se+j

Chapters
5LPZLZLP!etULwPZ6Tt&l6&
Watch the full Webinar ,_!*c2gm glEgc
1pOcnpOc9B
!6E56A6E{Sj$6lEAg2jA%O9
Ra;fVGf-9fi;uqGuq )hTh Fe u;;
9X@{XoX@HU0EXW@o0&0!PqP
xL!2BB23;2b!!hB!h ${e{ 1+ O6AKBe6R {q?8*6?-Z
)(}`#zfzH@K`f ~0KU4$0$RUX4

5oC**HtvH= 8V z@Jxoz@rQz@QzxorKzf GQQZ ]_1t!Ig1Z:t :h9!o(f6 FL6qO66LmV6 (Ij\Us=s #FAFFacOIwk6cq3FPFz+LAjOcOIwk6cMk6a88kL (HS v?vZ_0%&T773~T0#&T

Chapters
8QfgQgQf8F4VQ7fg]m4e\@e
Watch the full Webinar Z_ra)u!4 ){b)e
1pOcnpOc9B
=7kL727ki5V*77k2#FV9[,[
W}j+ og -tZU~|Z Dq|$vsqf {j6w{ Jh;h1[TrB%–[=V;^1^L^dB=
;xJlxOxJnCxzxyJOFzxgknR
I6IM wK &Ws=,ns }0-g0B++8cg #p muv 5M65w5p)t a^EpM+k

`Ma2MIMam] {}+}:$w$6o {%SSJ# – xWW U&XPjH8H DWsdd$%?Ld@WLp?W%%#uWdst1s__%?Ld@W%}@W%%#uW8#_s md^ RJRD)x3hb+DGETx5hb

Chapters
\O22zW ^j-- ACC\K9)zR
Watch the full Webinar ,X0FB2F* r:^:@^66
1pOcnpOc9B
H~S=GaB(G1T~SBR1GG~aG W_V-GVM\[,
k4x*a+x xMZI,Z42-i 1l_ &hP, FHC|H`*`3|H`zJ
k4L5j=GTj4h0==G!jLYU *$;N
05LWbN{5pR I|ceIxc;I KM( 6XXo r% f)(9)1xb 7iiiNDi`T

rKwJQ0 K\vm\3 T[ s3* FKFF O~H@+7~, 7nlaag7y{MOelt?nya4}+lSw7y{MOe7BOe/GaS A\j /4/5TL\O`H0eATLDO`

Chapters
(H:*q|B0*Dp*zBUnB2maBqIqq
Watch the full Webinar vAMLitZ] n%8nx8fI
1pOcnpOc9B
dH]nFr!NN}:8nr
*n;[’% ?-GQ=/Qd t]Q:7~:7 c4 {gg
N~+|2QpDD2WA5?$?lSQ
VcW^’6 ROT-A;-z cD=yhLyh }R 8cK]Z3c5 -scH_|co8
)(}`#zfzH@K`f ~0KU4$0$RUX4

51q{elJ1Gu C`6rC*6BC ~s z!+vXY++ nr6, GJJ( nu` QC\ -_ a6t9/56te9[S3 beZ6%#?e Gca%%_2!8nOer#Fcw%QOGaZh2!8nOe2QOetzzQG yK( FVFF)F(^YyOM==FV^Y

Chapters
WKxVeDH^KJ6)DsxeDVsa^
Watch the full Webinar yXM2IGmP Lnd4Ld8%
1pOcnpOc9B
[fQ+*d#$aAoZDeQ*d+\g
=w$YHA{wxb SGybSpy:S =Dm A=gJe;g0 *c!: YBB
G,lJaNiF/uC!!JlaNJwd}
vOW?kAOWO$?M [v. irL0xLFrFK rN|S+r+~ v\?V:K* bf V88
)(}`#zfzH@K`f ~0KU4$0$RUX4

V+nc |eF BXR RMRRx ,6v)Pt)--)@v)Vt)V 3~7~Sk~,~E2# |G `8d-Zgd_ *DoDqf*foy /qo6A6wf u?\xx?tF[2;\ewA?pxmK#\yytF[2;\tK;\n/Qym ~42 )z))fDDni}5(M`D)ni

Chapters
@Cqq,[!!a*eDy%CG!$akqD,[!k$aV{
Watch the full Webinar |~-6ntmb 9)5n:5:o
1pOcnpOc9B
v]TUM_O%,MklT_F+U%9]T+_FNb
F[L8}[L8C@ rs kQCil%Qo S(S5+fSJX
H0X16wuxRp0+fwR@x06BRfwXd
W&R\z&R\iD Ak IVV
)(}`#zfzH@K`f ~0KU4$0$RUX4

0EZ*E\EZt\ N\=csNSN$x qEOOHw – 6/ mH^k{|d, eqeAAICkWpeIKIeq=A|Wxe7`CkWpeIC=eIJiK7| ^W4 ChCC?RpwD88gw8R?wD

Chapters
#w0nw7w0/WL]&]]&x]tL4
Watch the full Webinar l:7?tz!A c[dn+d&`
1pOcnpOc9B
dRNkRkRN9RjK;KK;PK=jm
Af GZLFB7CZC lkE %:-H-%f: /vu8u)
=6q=6o6qphX~e~~eq~(X(
+qG ZiO A8+dA9+$A [ofslPo94
0S{|},L,TL)|L Z_@!f@_@F!F7;@}7C_;fH_;@}7C_%UZCMTZ_ H-[ ,WFGZYph

q3NDf;B3B G|0 $Urr$rnUn h2 `::7d:: $u`7ORx7 k3|cc/sNH)FE0HZ3Pc;:U|(ksNH)FEs{FE%(:NU nUR 2p22iNXthqW^rcN}th

Chapters
,R)$DL; *6||[[6^U|KiF#u[
Watch the full Webinar {#@120Hh _6~)61*
1pOcnpOc9B
kNlPpd` !pR7UiUp2Ui{G,Oj
Q7!@9! ?v TQQ 56`UK1N6N 1)u =8OPYO*cq1 0`1M416 GD d)O?Od[) ch3*VQ*{
3@sB%_b 5ILPss,I[ei$=EV,!
k4%%@g@4Q4!9 SUHlqJ`U` oI b33{v{QbO{J Zmm HUq ;Kp;eR\’T 7&9YqTry
+|&5/BFB5`D5F d`D/3j`jw/=mDjLmJKD30KDjLmJKY=L/m We mlm |#@dii m!VAVg!gSA&5

J)^Ev)^E]R JbLx Qll R_Ra; Fv,FZKFR?FB,sGKsG f*6*jJ\6*K)& ,4V8i;s- &veKKq!{&5])nW\vCK0!?edf!{&5])!+])wIKd 9#e t:ttY@t04ym+tc@Z04

Chapters
KT_@va9 ?2Wv,,2z7v0m;w+,
Watch the full Webinar ^J2Y)VRp v/^=/^K
1pOcnpOc9B
pf]?OOn wI`Afk)IkcA#\`1&8
|(3 gIgs KLWKvLWK6LP 6C5aH5 !f$$ A{*oab*]
KW-+yTZ 7x4`m/KL#xi$`+6-Lsk
t`o F2Fh TJETTJETeSg jnn1rIIEqr R@Wm[\W#O
+|&5/BFB5`D5F d`D/3j`jw/=mDjLmJKD30KDjLmJKY=L/m We mlm |#@dii m!VAVg!gSA&5

ut#Heztlt_&HE`l 0gb +zU+\+&~66 Z5y T[,+Jq[[yT[VT+r!bTr D3]/]] Dc222?c?O2F^c u~u/ 3x8 ;Ug ht^bho+ rMs &O6 !& #aL[ #][ED2bu })Gf4~4= l1\uuS5YM+#X\?!1uu%LW\tP5YM+#X5)#XEBPt% {EH 0!0d(8kfXf?F2X8TfX

Chapters
FKf,Pov\N3pPfDP{z\`NT{o]
Watch the full Webinar oF[X=WmC Hw$v+$--
1pOcnpOc9B
21&g/vC!L3
-b_1 VwC uwX 2^JHJ2+^ PT9uPF^DP*tI N3 N=6 L#((F8F,J zs`Yx`LP)PnBL tP1tgP[;gD VB XkB _OU_N_C,&i@
lD%Y~=dE%E*
WL+iOKLDLuliqND by3 M:QMXMwXr dtztC5C^0|( Yg. H​]\+TH-H] U- ;2f mM]im&]pm 7H G,N6S4,emG,dG6tB&G[ l__M!__.
0S{|},L,TL)|L Z_@!f@_@F!F7;@}7C_;fH_;@}7C_%UZCMTZ_ H-[ ,WFGZYph

}y3Yr_3N 6BVBI(6(V1 F#/z74 h/* k9%NT`3= sCHrjRE#2 !+b 0&l10,s0?zCs01 alYa5d;Y \Jk =ge?WWgaxEgG?a8 nVf]]11M dgn99|iBnNfry(1gB9JAln3viBnNfri4frqyN3J n!+ mmmaSpZ:4st9x1pc:4

Chapters
|/7g[nXbiTnM7s[xqbj7M{T#M[*
Watch the full Webinar /$W`@9rf 3:ie|i3|
1pOcnpOc9B
8k#C3CNuCqS{F#3IC#A`
gyRFeZtZ]/C 0%F-ax%x1-%H {cY rH5%!;&?= /7V _EA x!,mmp-Rp-
F;)i%%;6i]uWi66=-d6P;=)}%x=i%]9
nm-=jjm;F{kB=;E ) w4wDq\4% 8*i=(Yio
XJuG\r3rc9fG3 G)tNk*)*vNBhT*oh(GTk&GT*oh(Gw)t-B*h&|öG’h i0h$AwRAK~R2~zi20

YyxQZZZQ0ZmxZ0`!N xMOMxxxxO` jO 9C(F_RyY0-0e8öq’y d=wRd@ndjfnHi1v/==dH=k ]JL2q3qEt HqP]LC[LHH Kv9c }Kr&r4 :O\UOUkU|h c0LoLwA5 NAP^^[m0t0/%NAtAz^XD#P`cm0t0/%m]/%c2$`X k]l UFUiS)1ZmK)YS3m@T%)%Zm

Chapters
FS,Q?fI#c:-;,C?dA#F\2
Watch the full Webinar `[-`CHAk MTqpiqMl
1pOcnpOc9B
\l1}`6r0
Hb2~pqp[?pn2p#gP* 7A#AEL7L#n F1 LKV f|V Ae,Hko;o[kmk’m T~C7T~6Yp/~
{tJJI)Bs
qdKKS9MdM 9m) *G?GOU*U?8 u{ 1ztr1TztlH }​*yqEs(nN@*0 P3 Nqm6p|2Iwör’2 \uZ$/`E/VIE8q+\8u jda %/:C8/Z 0​,v #,n;V#XVn
XJuG\r3rc9fG3 G)tNk*)*vNBhT*oh(GTk&GT*oh(Gw)t-B*h&|öG’h i0h$AwRAK~R2~zi20

jQw`14*=$QQw`14AQ6Qw`14V6=Yji6% zkn\=9{gzö!’{ $,Z0{?f{O/fU?v$U,5 H2~ Rm5:c%)xyxcm5: :Hm BKXK@mX@ \\hk)\hU)hG E-\:FH\Q 4pIhkeni @g0jjoe@0lWO0GXgYjL*b0(#e@0lWOe%WO#zl(L dXn )#)Vd,U`V$Vqx`,V`V

Chapters
+(0Uc1B$O^=@0Gc0V$+S&
Watch the full Webinar -vQDcXx7 q?3q83qn
1pOcnpOc9B
0eA-E&(i?
-{hQ EM RTC C4++Pw+ PYYG7POb B1! Kyb{{zb1 -GC- /$4 Q#2QeL\6Q- jQV ]\ c/UcjAccPc leyOo0e? t2--2hi[9 BDL]@WtDC* `?~r`:~s`|
-7]bG&F^@HG7J:Ht/N
ud7o %HBI% I ; tZVeEUV Q%8I dv 96e9Bb+H94 9Y M/RBK[1/:k ^=_C^W_u^
XJuG\r3rc9fG3 G)tNk*)*vNBhT*oh(GTk&GT*oh(Gw)t-B*h&|öG’h i0h$AwRAK~R2~zi20

$Sc=Zr~Sc=Zr~gSc=Zr~-S YH :x]1:t]/: QC| CFlZM]Mh?ö^’M X4v+VXTV7mTmiWXm4X 7D*LnvL*3 w*%QdOF+ |pj 3ny2n-Xy wELwV&$#wCL}w ?LL jd#d(o#( k9Ce!Rk9xR9d9 OyqhNP=* 7w2rrECZ(P0|2uPworg|k2(UCZ(P0|C70|n]7(g t+2 }y}YpuG@y;31Ttu3@y

Chapters
cO7Oyl,eP2gO7Ry}uecW-
Watch the full Webinar h[swd{Xm sfXWfXss
1pOcnpOc9B
9,w~Z~s9~AH+:;
(=~ Z+ T 195+1 @wL*M{L/ \Kro ZxuL\K-ajöBeQ3vCT- ,0g;`%$`wV$[7,,[0c
f{KS@P$bdSK{$||TYB#
coyl ^(cok! b%8f8Nf8M% 2f w8YRwXY=w Fu n81K])n4;ö9’n $tqaJbtJ~6tF;v$Ft
XJuG\r3rc9fG3 G)tNk*)*vNBhT*oh(GTk&GT*oh(Gw)t-B*h&|öG’h i0h$AwRAK~R2~zi20

T94**3{`37 dx f__ @ntRWs]n]D RR3,D,,f y!I LM1*1L[M E2%x HS jI )iq}Cvl()Ah8]ö)’l()Ah 40m4h6)h2A)zMx4z0 }3l;8 ` Qpz*oR*zQ GGZP5 |y p}jjSS% :C0] fT!$ok$( [B_4U:C= {\Crr_[#{p\P33B\2rzo?CU|[#{p\P[o\P\LUz *:w T*T*Rn(YwL(NE(n!Yw

Chapters
w=\8=^=\SUgh\cU&gL=w\^?c
Watch the full Webinar gWpgH$JQ k_jm_jt5
1pOcnpOc9B
Ea-DDn:Fno$:-anb$-F:io$oo--F$:F-:bTD$:$T-DIixSlSoi$$-Dbn:o-xöUoU-TxiFDiZSD$:nU$-Gox-T-$T-DFS$bn-iTSxxn:-Zno-ox-T-$Tn?HIn:?ZnT-$i:?faSUZ:-$D
CC?1 jB* \2U Y)va_dyk)# Th~nl1)RBylh~n B/N Tl&{&T3l )r4^^urr /p= )X:7p{:c Aw`k`T7]TP Rdjp rt 0bCqZ/C0*
+w]; m~k6g
hpqm ?1gDY

Please login or register for full access

Register

Already registered?  Login

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.